Explore the words cloud of the REGMAMKID project. It provides you a very rough idea of what is the project "REGMAMKID" about.
The following table provides information about the project.
Coordinator |
FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA
Organization address contact info |
Coordinator Country | Spain [ES] |
Total cost | 1˙499˙604 € |
EC max contribution | 1˙499˙604 € (100%) |
Programme |
1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC)) |
Code Call | ERC-2014-STG |
Funding Scheme | ERC-STG |
Starting year | 2015 |
Duration (year-month-day) | from 2015-11-01 to 2020-10-31 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA | ES (BARCELONA) | coordinator | 1˙499˙604.00 |
Kidney non-endocrine functions are primarily performed by millions of individual integral units called nephrons. Although the adults of simple vertebrates (fish, amphibians and reptiles) have the ability to regenerate entire nephrons by a process called “nephron neogenesis”, this capacity is absent in birds and mammals. In this regard we have observed, for the first time, that the murine neonatal kidney is able to generate new nephrons after the resection of the 20 per cent of the kidney mass. In the same manner, our recent published data on the generation of human kidney organoids ex vivo from kidney disease derived induced pluripotent stem cells (iPS), demonstrates the suitability of iPS technology to establish an unprecedented platform for drug screening, disease modelling and kidney regeneration. Thus, with support from REGMAMKID we will carry out a dual strategy for kidney regeneration and therapy. For kidney regeneration, we will make use of our newly developed mouse model of neonatal kidney regeneration and identify the molecular and epigenetic drivers responsible for this process. For kidney therapy, we will generate specific kidney cell populations with therapeutic potential such as podocytes and tubular epithelial cells by combining emerging cutting-edge technologies from the fields of cellular reprogramming and pluripotent stem cells differentiation. Making use of the tools developed in REGMAMKID we will model two different genetic kidney disorders: one affecting the podocyte (Congenital Nephrotic Syndrome) and other leading to an excessive proliferation of tubular epithelial cells (Autosomal Dominant Polycistic Disease). These studies will significantly impact on our understanding of kidney disease and healing.
year | authors and title | journal | last update |
---|---|---|---|
2016 |
Elena Garreta, Lorena de Oñate, M. Eugenia Fernández-Santos, Roger Oria, Carolina Tarantino, Andreu M. Climent, Andrés Marco, Mireia Samitier, Elena MartÃnez, Maria Valls-Margarit, Rafael Matesanz, Doris A. Taylor, Francisco Fernández-Avilés, Juan Carlos Izpisua Belmonte, Nuria Montserrat Myocardial commitment from human pluripotent stem cells: Rapid production of human heart grafts published pages: 64-78, ISSN: 0142-9612, DOI: 10.1016/j.biomaterials.2016.04.003 |
Biomaterials 98 | 2020-03-17 |
2016 |
C. Eguizabal, L. Herrera, L. De Oñate, N. Montserrat, P. Hajkova, J. C. Izpisua Belmonte Characterization of the Epigenetic Changes During Human Gonadal Primordial Germ Cells Reprogramming published pages: 2418-2428, ISSN: 1066-5099, DOI: 10.1002/stem.2422 |
STEM CELLS 34/9 | 2020-03-17 |
2018 |
Elena Garreta, Federico González, Núria Montserrat Studying Kidney Disease Using Tissue and Genome Engineering in Human Pluripotent Stem Cells published pages: 48-59, ISSN: 1660-8151, DOI: 10.1159/000480710 |
Nephron 138/1 | 2020-03-17 |
2016 |
Elena Garreta, Andres Marco, Juan Carlos Izpisua Belmonte, Nuria Montserrat Genome editing in human pluripotent stem cells: a systematic approach unrevealing pancreas development and disease published pages: 76-76, ISSN: 2313-0792, DOI: 10.21037/sci.2016.10.11 |
Stem Cell Investigation 3 | 2020-03-17 |
2016 |
Nuria Montserrat, Elena Garreta, Juan Carlos Izpisua Belmonte Regenerative strategies for kidney engineering published pages: 3303-3324, ISSN: 1742-464X, DOI: 10.1111/febs.13704 |
The FEBS Journal 283/18 | 2020-03-17 |
2017 |
Elena Garreta, Roger Oria, Carolina Tarantino, Mateu Pla-Roca, Patricia Prado, Francisco Fernández-Avilés, Josep Maria Campistol, Josep Samitier, Nuria Montserrat Tissue engineering by decellularization and 3D bioprinting published pages: , ISSN: 1369-7021, DOI: 10.1016/j.mattod.2016.12.005 |
Materials Today | 2020-03-17 |
2018 |
Elena Garreta, Nuria Montserrat, Juan Carlos Izpisua Belmonte Kidney organoids for disease modeling published pages: 12552-12553, ISSN: 1949-2553, DOI: 10.18632/oncotarget.24438 |
Oncotarget 9/16 | 2020-03-17 |
2018 |
Elena Garreta, Sonia Sanchez, Jeronimo Lajara, Nuria Montserrat, Juan Carlos Izpisua Belmonte Roadblocks in the Path of iPSC to the Clinic published pages: 14-18, ISSN: 2196-3029, DOI: 10.1007/s40472-018-0177-x |
Current Transplantation Reports 5/1 | 2020-03-17 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "REGMAMKID" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "REGMAMKID" are provided by the European Opendata Portal: CORDIS opendata.
Reprogramming Conformation by Fluorination: Exploring New Areas of Chemical Space
Read MoreFrom GWAS to functional studies: Tackling the complex nature of brain disorders
Read MoreThe wide-spread bacterial toxin delivery systems and their role in multicellularity
Read More